The climb up the steel steps is dizzying--like ascending the tower of a European church, except the steps lead to a platform bolted to the side of a gleaming new chemical plant.
"Here we describe molecular implementations of integrated digital circuits, including a three-input AND logic gate, a two-input multiplexer, and 1-to-2 decoder using allosteric ribozymes. Furthermore, we demonstrate a multiplexer–decoder circuit. The ribozymes are designed to seek-and-destroy specific RNAs with a certain length by a fully computerized procedure. The algorithm can accurately predict one base substitution that alters the ribozyme’s logic function. The ability to sense the length of RNA molecules enables single ribozymes to be used as platforms for multiple interactions. These ribozymes can work as integrated circuits with the functionality of up to five logic gates. The ribozyme design is universal since the allosteric and substrate domains can be altered to sense different RNAs. In addition, the ribozymes can specifically cleave RNA molecules with triplet-repeat expansions observed in genetic disorders such as oculopharyngeal muscular dystrophy. Therefore, the designer ribozymes can be employed for scaling up computing and diagnostic networks in the fields of molecular computing and diagnostics and RNA synthetic biology." http://bit.ly/Noz6uN
"Chemical tags are now viable alternatives to fluorescent proteins for labeling proteins in living cells with organic fluorophores that have improved brightness and other specialized properties. Recently, we successfully rendered our TMP-tag covalent with a proximity-induced reaction between the protein tag and the ligand-fluorophore label. This initial design, however, suffered from slow in vitro labeling kinetics and limited live cell protein labeling. Thus, here we report a second-generation covalent TMP-tag that has a fast labeling half-life and can readily label a variety of intracellular proteins in living cells. Specifically, we designed an acrylamide-trimethoprim-fluorophore (A-TMP-fluorophore v2.0) electrophile with an optimized linker for fast reaction with a cysteine (Cys) nucleophile engineered just outside the TMP-binding pocket of Escherichia coli dihydrofolate reductase (eDHFR) and developed an efficient chemical synthesis for routine production of a variety of A-TMP-probe v2.0 labels. We then screened a panel of eDHFR:Cys variants and identified eDHFR:L28C as having an 8-min half-life for reaction with A-TMP-biotin v2.0 in vitro. Finally, we demonstrated live cell imaging of various cellular protein targets with A-TMP-fluorescein, A-TMP-Dapoxyl, and A-TMP-Atto655. With its robustness, this second-generation covalent TMP-tag adds to the limited number of chemical tags that can be used to covalently label intracellular proteins efficiently in living cells. Moreover, the success of this second-generation design further validates proximity-induced reactivity and organic chemistry as tools not only for chemical tag engineering but also more broadly for synthetic biology." http://1.usa.gov/OYkJj7
"This may be the first paper (review article) from the EteRNA game. RNA design will be an exciting topic for the future."
Squaring theory with practice in RNA design by JP Bida, R Das
"Ribonucleic acid (RNA) design offers unique opportunities for engineering genetic networks and nanostructures that self-assemble within living cells. Recent years have seen the creation of increasingly complex RNA devices, including proof-of-concept applications for in vivo three-dimensional scaffolding, imaging, computing, and control of biological behaviors. Expert intuition and simple design rules — the stability of double helices, the modularity of noncanonical RNA motifs, and geometric closure — have enabled these successful applications. Going beyond heuristics, emerging algorithms may enable automated design of RNAs with nucleotide-level accuracy but, as illustrated on a recent RNA square design, are not yet fully predictive. Looking ahead, technological advances in RNA synthesis and interrogation are poised to radically accelerate the discovery and stringent testing of design methods."
The Verge is a technology-focused news publication founded in 2011 by Joshua Topolsky and Marty Moe in partnership with Vox Media and its CEO Jim Bankoff.
By: Caroline Channing August 9, 2012 4:20 PM. The University of Wisconsin-Madison has been awarded $1M by the W.M. Krek Foundation to develop “synthetic biology foundries” which should speed up the synthesis of new genes.
"As the availability of DNA sequence information has grown, so has the need to replicate DNA sequences synthetically. Synthetically produced DNA sequences allow the researcher to exert greater control over model systems and allow for the combinatorial design and construction of novel metabolic and regulatory pathways, as well as optimized protein-coding sequences for biotechnological applications. This utility has made synthetically produced DNA a hallmark of the molecular biosciences and a mainstay of synthetic biology. However, synthetically produced DNA has a significant shortcoming in that it typically has an error rate that is orders of magnitude higher when compared to DNA sequences derived directly from a biological source. This relatively high error rate adds to the cost and labor necessary to obtain sequence-verified clones from synthetically produced DNA sequences. This unit describes a protocol to enrich error-free sequences from a population of error-rich DNA via treatment with CEL I (Surveyor) endonuclease. This method is a straightforward and quick way of reducing the error content of synthetic DNA pools and reliably reduces the error rates by >6-fold per round of treatment..."
"Synthetic Biologics is giving Intrexon $3.6 million worth of its shares as part of a second exclusive collaboration, through which the firm will use Intrexon’s technologies to develop monoclonal antibodies against initially three, but potentially five, different infectious diseases. Synthetic Biologics and Intrexon’s initial collaboration is focused on the development and commercialization of a DNA-based therapeutic for the treatment of pulmonary arterial hypertension (PAH).
Under terms of the new deal Synthetic Biologics will have broad access to Intrexon’s full suite of technologies, including its core UltraVector™ platform for the design, construction, and testing of genetic components, mAbLogix™ platform for in vitro B-cell library production, Laser-enabled analysis and processing™ (LEAP™) cell processing station, and genome/protein engineering expertise. The addition of the $3.6 million worth of shares to Intrexon's existing holding in the firm will give it an 18% stake in Synthetic Biologics.
“Intrexon has state-of-the art technologies and efficient processes that have tremendous potential for the production of a broad spectrum of fully human antibodies,” remarks Jeffrey Riley, Synthetic Biologics’ CEO. “This expanded relationship gives us access to this paradigm-changing platform.”
The latest Synthetic Biologics agreement is the second for Intrexon this month. Last week the firm inked an exclusive research collaboration with BioLife Cell Bank, focused on leveraging Intrexon’s technologies to develop autologous, genetically modified stem cell therapeutics for spinal muscular atrophy. And a few weeks earlier the firm inked an alliance with Oragenics through which the latter intends to develop broad spectrum lantibiotic candidates against infectious diseases in humans and companion animals." http://bit.ly/Nk13Um
Cheemeng Tan , Shih-Jie Lo , Philip LeDuc and Chao-Min Cheng
"The development of optofluidic-based technology has ushered in a new era of lab-on-a-chip functionality, including miniaturization of biomedical devices, enhanced sensitivity for molecular detection, and multiplexing of optical measurements. While having great potential, optofluidic devices have only begun to be exploited in many biotechnological applications. Here, we highlight the potential of integrating optofluidic devices with synthetic biological systems, which is a field focusing on creating novel cellular systems by engineering synthetic gene and protein networks. First, we review the development of synthetic biology at different length scales, ranging from single-molecule, single-cell, to cellular population. We emphasize light-sensitive synthetic biological systems that would be relevant for the integration with optofluidic devices. Next, we propose several areas for potential applications of optofluidics in synthetic biology. Finally, we discuss potential applications of optofluidic devices in the diagnosis of infectious diseases."
"With NASA’s Curiosity Rover safely on Mars and ready to search for signs of life, back on Earth attempts are underway to engineer bacteria that could thrive on the Red Planet.
A team of undergraduates from Stanford and Brown Universities are busy applying synthetic biology to space exploration, outfitting microbes to survive extreme Martian conditions and produce resources needed to sustain a human colony.
Though Mars is potentially a place where life may have survived at some point, it is not an especially friendly environment, and thriving there will not be easy — for humans or microbes. The average surface temperature of Mars is minus 80 degrees Fahrenheit, and the almost-nonexistent atmosphere is 95 percent carbon dioxide. Although water exists in Mars’ ice caps and there’s some evidence that giant oceans once covered the planet, today it’s essentially a deep-frozen desert. Colonizing Mars would be challenging and pricey.
“Obviously, bringing up heavy machinery or building materials is going to be really expensive,” said Brown student and team captain Ben Geilich. “The benefit of having bacteria that can do this for you is they’re really small and very light. Once there, they could grow food, produce medicine, extract minerals, and build building material.”
The project is part of the International Genetically Engineered Machines (iGEM) challenge, an annual synthetic biology competition that pits students around the world against each other in attempts to ingeniously hack living cells to perform new tasks. In a regional iGEM meet in October, Geilich’s team will present what they call a Hell Cell, a suite of genetically engineered parts that could enable a bacterium to withstand severe cold, dryness and radiation. Geilich calls it “a genetic box of crayons for extremophile conditions.”....." http://bit.ly/QMNcuU
This new inventory begins to track the impact of synthetic biology on a wide range of applications, from energy and pharmaceuticals to chemicals and food ingredients.
"With the completion of a myriad genome sequencing projects, the emergence of metagenomics and significant progress in understanding and building living systems, synthetic biology engineering has expanded into many applications including the rational optimization of complex pathways, construction and characterization of genetic circuits of increasing complexity and the functional re-design of existing biological systems. Design, construction and validation of genetic circuit, pathway and genome engineering workflows are powered by a comprehensive toolbox that includes intelligent metabolic and genetic design software, sequence verified, scaled, cost-effective gene synthesis and precise, genetic assembly and editing technologies able to address genetic constructs of various size ranges. We present a growing set of integrated technologies that provide state-of-the-art rational genetic design and simulation, gene synthesis and seamless, simultaneous, flexible, and highly efficient assembly, editing and transfer of genetic elements designed for a wide size range (10s to 100,000s base pairs). The paradigm of next generation deep sequencing to build a foundational understanding at the genomic and transcriptome levels enabling initial metabolic models to facilitate directed engineering will be presented. Scaled, cost-effective gene synthesis methods, formats and process considerations will be discussed. Tools for vector construction, higher order HTP assembly and precision editing of genetic elements in vitro and in vivo will be described. Desk-top and web-based assembly/design software tool and resources to design and manipulate large DNA constructs in silico will be presented in the context of research and applied technologies to enhance the development of synthetic biology engineering capabilities." http://bit.ly/P964ku
"Citizen scientists have recently published a paper in PLOS One tracking human male migration and expansion, using the R1b1a2 gene on the Y chromosome. What makes this work special is the citizen scientist aspect of it. Following on from our previous article on bioinformatics as a growing hobby, this work shows that such a hobby can be a truly useful form of crowd sourced science. One of the authors of the paper remarked:
We’ve tried to show how such progress can be facilitated by an engaged community of individuals, with varied and complementary skills, connected via the Internet." http://bit.ly/NmfyXM
*Discovery of Western European R1b1a2 Y Chromosome Variants in 1000 Genomes Project Data*
by Richard A. Rocca, Gregory Magoon, David F. Reynolds, Thomas Krahn, Vincent O. Tilroe, Peter M. Op den Velde Boots, Andrew J. Grierson
"The authors have used an online community approach, and tools that were readily available via the Internet, to discover genealogically and therefore phylogenetically relevant Y-chromosome polymorphisms within core haplogroup R1b1a2-L11/S127 (rs9786076). Presented here is the analysis of 135 unrelated L11 derived samples from the 1000 Genomes Project. We were able to discover new variants and build a much more complex phylogenetic relationship for L11 sub-clades. Many of the variants were further validated using PCR amplification and Sanger sequencing. The identification of these new variants will help further the understanding of population history including patrilineal migrations in Western and Central Europe where R1b1a2 is the most frequent haplogroup. The fine-grained phylogenetic tree we present here will also help to refine historical genetic dating studies. Our findings demonstrate the power of citizen science for analysis of whole genome sequence data...." http://bit.ly/NqyjIg
"The availability of custom synthetic gene-length DNA products removes numerous bottlenecks in research efforts, making gene synthesis an increasingly common commercial service. However, the assembly of synthetic oligonucleotides into large, custom DNA constructs is not especially difficult, and performing "in-house" gene synthesis has time and cost advantages. This unit will treat both the concerns of design and physical assembly in gene synthesis, including how to design DNA sequences for synthesis and the design of overlapping oligonucleotide schemes to ensure facile assembly into the final product. Assembly is accomplished using a reliable series of PCR reactions, with a troubleshooting assembly protocol included, which not only assembles difficult sequences but allows identification of the source of a failure down to a pair of oligonucleotides" http://1.usa.gov/QiZ5Cv
"Prof. Joseph Ayers' presentation at the 4th New Phytologist Workshop (Synthetic Biology). More videos and information from the Workshop can be found at: http://www.newphytologist.org/synthetic/default.htm
Abstract: The adaptive capabilities of underwater organisms result from layered exteroceptive reflexes responding to gravity, impediment, and hydrodynamic and optical flow. In combination with taxic responses to point sources of sound or chemicals, these reflexes allow reactive autonomy in the most challenging of environments. We are developing a new generation of lobster and lamprey-based robots that operate under control by synaptic networks rather than algorithms. The networks are based on the command neuron, coordinating neuron, central pattern generator architecture, code sensor input as labeled lines and activate shape memory alloy-based artificial muscle through a simple neuromuscular interface. In a separate project, we are developing an electronic nervous system to control the flight of RoboBee. In all systems, the behavioral set results from chaining sequences of exteroceptive reflexes released by sensory feedback from the environment. In parallel we are exploring principles of synthetic biology to develop biohybrid robots and sensors and actuators that can interface to electronic nervous systems. Cyberplasm combines an aVLSI electronic nervous system with engineered cellular sensors and engineered muscle that responds to light generated by oLEDs gated by neuron action potentials. In the ONR MURI we are integrating programmable bacteria with RoboLobster and RoboLamprey to enhance chemosensory capabilities." http://bit.ly/NhwmiR
To get content containing either thought or leadership enter:
To get content containing both thought and leadership enter:
To get content containing the expression thought leadership enter:
You can enter several keywords and you can refine them whenever you want. Our suggestion engine uses more signals but entering a few keywords here will rapidly give you great content to curate.